With the analysis among 331 patents, we discovered top 102 key players by total patent application. Espervita Therapeutics, Inc., SuperGen, Inc., International Institute of Cancer Immunology, Inc. are dominant in this area. They take 12.99% of the total patent filing.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
California, United States
Patent: 13
International Institute of Cancer Immunology, Inc.
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
Shanghai Biowindow Gene Development Co. Ltd.
Shanghai Shi, China
Patent: 9
Secarna Pharmaceuticals Gmbh & Co.
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Glactone Pharma Development AB
With the analysis among 29 patents, we discovered top 5 start-ups by total patent application. Espervita Therapeutics, Inc., Galvanize Therapeutics, Inc., Beijing Geneplus Technology Co., Ltd. are active in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Beijing Geneplus Technology Co., Ltd.
Beijing Shi, China
Patent: 1
Institut National de la Santé et de la Recherche Médicale
National Institutes for Quantum & Radiological Science & Tech
Chiba-ken, Japan
Patent: 1
With the analysis among related 181 patents applied in the last 5 years. We discover 63 most active companies in this area. The fast-growing Espervita Therapeutics, Inc., Sumitomo Pharmaceuticals Co., Ltd., International Institute of Cancer Immunology, Inc. take 22.10% of patent filing during this period.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
International Institute of Cancer Immunology, Inc.
Secarna Pharmaceuticals Gmbh & Co.
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 6
Yonsei Industry-Academic Cooperation Foundation
National Yang Ming Chiao Tung University
Taiwan Province, China
Patent: 5
Shandong Sheng, China
Patent: 4
With the analysis among related 181 patents in last 5 years, we discover 59 new entrants. Espervita Therapeutics, Inc., Sumitomo Pharmaceuticals Co., Ltd., International Institute of Cancer Immunology, Inc. are the most active new entrants in this area.
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 10
International Institute of Cancer Immunology, Inc.
Secarna Pharmaceuticals Gmbh & Co.
Galvanize Therapeutics, Inc.
California, United States
Patent: 6
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 6
Yonsei Industry-Academic Cooperation Foundation
National Yang Ming Chiao Tung University
Taiwan Province, China
Patent: 5
Shandong Sheng, China
Patent: 4
With the analysis among 133 patents, we discovered top 38 universities and scientific research institutions by total patent application. Dresden University of Technology, University of Tokyo, LaTrobe University are dominant in this area. They take 12.03% of the total patent filing.
Dresden University of Technology
Sachsen, Germany
Patent: 6
Victoria, Australia
Patent: 5
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 5
National Yang Ming Chiao Tung University
Taiwan Province, China
Patent: 5
Shandong Sheng, China
Patent: 4
Sachsen, Germany
Patent: 4
The Johns Hopkins University
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 2
Texas, United States
Patent: 2